Literature DB >> 18787776

Phenotype of exogenous microparticle-containing pigment cells of the human Peyer's patch in inflamed and normal ileum.

V Thoree1, J Skepper, H Deere, L C Pele, R P H Thompson, J J Powell.   

Abstract

OBJECTIVES: Pigmented cells, that contain inert, submicron-sized dietary particles, are a consistent feature of the base of human Peyer's patches (PP). We aimed (i) to phenotype these intestinal pigment cells (PC) in archival tissue specimens and (ii) to establish whether PC phenotype is altered in inflammatory conditions, especially Crohn's disease (CD).
METHODS: PCs contained within PP were identified by routine haematoxylin and eosin (H&E) staining and dark field microscopy of archival ileal sections for: adenocarcinoma (n=16), colonic CD (n=23), non-CD colitis (n=10). Paraffin-embedded serial sections were graded for microscopic inflammation and then investigated immunohistochemically with antibodies against CD68, MAC387, CD14, CD11b, CD15, CD1a, S100, HLA-DR, CD86 and Cathepsin D. Analyses were by light and confocal microscopies.
RESULTS: The majority of PCs were CD68 positive (circa 80%) with a minority (circa 20%) staining for MAC387. Microparticles were mainly identified within cathepsin D negative lysosomal compartments. Histological inflammatory grade and disease type had no influence on cell phenotype.
CONCLUSIONS: The microparticle-containing PCs of the PP base are mainly mature macrophages (CD68) of low metabolic and immunological activity. There is no evidence of differential PC phenotype or activation in differing disease states, including CD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787776     DOI: 10.1007/s00011-007-7216-x

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  7 in total

1.  Gastrointestinal Absorption and Toxicity of Nanoparticles and Microparticles: Myth, Reality and Pitfalls explored through Titanium Dioxide.

Authors:  Alessandra Barreto da Silva; Michelle Miniter; William Thom; Rachel E Hewitt; John Wills; Ravin Jugdaohsingh; Jonathan J Powell
Journal:  Curr Opin Toxicol       Date:  2020-02-28

2.  Small and dangerous? Potential toxicity mechanisms of common exposure particles and nanoparticles.

Authors:  Rachel E Hewitt; Helen F Chappell; Jonathan J Powell
Journal:  Curr Opin Toxicol       Date:  2020-01-30

3.  A Palmitoylethanolamide Producing Lactobacillus paracasei Improves Clostridium difficile Toxin A-Induced Colitis.

Authors:  Giuseppe Esposito; Chiara Corpetti; Marcella Pesce; Luisa Seguella; Giuseppe Annunziata; Alessandro Del Re; Martina Vincenzi; Roberta Lattanzi; Jie Lu; Walter Sanseverino; Giovanni Sarnelli
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

4.  Imaging flow cytometry assays for quantifying pigment grade titanium dioxide particle internalization and interactions with immune cells in whole blood.

Authors:  Rachel E Hewitt; Bradley Vis; Laetitia C Pele; Nuno Faria; Jonathan J Powell
Journal:  Cytometry A       Date:  2017-09-20       Impact factor: 4.355

5.  The antiprotozoal drug pentamidine ameliorates experimentally induced acute colitis in mice.

Authors:  Giuseppe Esposito; Elena Capoccia; Giovanni Sarnelli; Caterina Scuderi; Carla Cirillo; Rosario Cuomo; Luca Steardo
Journal:  J Neuroinflammation       Date:  2012-12-23       Impact factor: 8.322

6.  Pro-inflammatory adjuvant properties of pigment-grade titanium dioxide particles are augmented by a genotype that potentiates interleukin 1β processing.

Authors:  Sebastian Riedle; Laetitia C Pele; Don E Otter; Rachel E Hewitt; Harjinder Singh; Nicole C Roy; Jonathan J Powell
Journal:  Part Fibre Toxicol       Date:  2017-12-08       Impact factor: 9.400

7.  Pharmaceutical/food grade titanium dioxide particles are absorbed into the bloodstream of human volunteers.

Authors:  Laetitia C Pele; Vinay Thoree; Sylvaine F A Bruggraber; Dagmar Koller; Richard P H Thompson; Miranda C Lomer; Jonathan J Powell
Journal:  Part Fibre Toxicol       Date:  2015-09-02       Impact factor: 9.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.